BSECompany UpdateFundraise4 Sept 2026
Kronox Lab Sciences Ltd
IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Kronox Lab Sciences Ltd ("Target Company").
Kronox Lab Sciences Ltd has received a draft letter of offer from IIFL Capital Services Ltd, the manager to the open offer, regarding an open offer by Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited to acquire up to 95,70,000 equity shares representing 25.79% of the voting share capital at ₹157.27 per share.
BSECompany Update30 Aug 2026
Kronox Lab Sciences Ltd
Newspaper Publicaiton of 17th Annual General Meeting to be held on Wednesday, 16th September, 2026.
Kronox Lab Sciences Ltd has published a notice of its 17th Annual General Meeting to be held on September 16, 2026, through video conferencing.
BSECompany UpdateM&A28 Aug 2026
Kronox Lab Sciences Ltd
Detailed Public Statement ("DPS") has been published by IIFL Capital Services Limited acting as the Manager on behalf of INDO BORAX and Chemicals Limited ("Acquirer") along with Zenrock ....
Kronox Lab Sciences Ltd has announced the publication of a detailed public statement by IIFL Capital Services Ltd on behalf of Indo Borax and Chemicals Ltd and Zenrock Chemicals Private Ltd regarding an open offer to acquire equity shares of Kronox Lab Sciences Ltd.
BSECompany UpdateM&A28 Aug 2026
Kronox Lab Sciences Ltd
IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and 4 read with Regulations 13(4), 14(3), 15(2) ....
Kronox Lab Sciences Ltd has received an open offer from Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited to acquire its equity shares.
BSECorp. ActionDividend24 Aug 2026
Kronox Lab Sciences Ltd
Record Date for the purpose of Final Dividend as fixed by the Company is Wednesday, September 09, 2026
Kronox Lab Sciences Ltd has fixed September 09, 2026, as the record date for determining the eligibility of shareholders for the final dividend for the financial year ended March 31, 2026.
BSEAGM/EGMResults24 Aug 2026
Kronox Lab Sciences Ltd
In terms of Regulation 30 of SEBI (LODR) Regulations, 2015 please find enclosed Notice of 17th Annual General Meeting of Shareholders to be held on Wednesday, September 16, 2026.
Kronox Lab Sciences Ltd has announced its 17th Annual General Meeting (AGM) to be held on September 16, 2026, through video conferencing. The meeting will consider and adopt the audited standalone financial statement for the financial year ended March 31, 2026, along with the reports of the Board of Directors and the Auditors. The meeting will also consider a final dividend of Rs. 0.50 per equity share for the financial year 2025-26. Additionally, the meeting will ratify the remuneration payable to the Cost Auditors for the financial year 2026-27.
BSEOthersResults24 Aug 2026
Kronox Lab Sciences Ltd
Revised Submissoin of Annual Report for the year 2025-26
Kronox Lab Sciences Ltd has revised its submission of Annual Report for the year 2025-26, along with Notice of 17th Annual General Meeting to be held on September 16, 2026, due to a clerical mistake in Event no given by Services provider conducting AGM.
BSEOthersResults24 Aug 2026
Kronox Lab Sciences Ltd
Anuual Report for the year 2025-26
Kronox Lab Sciences Ltd has submitted its annual report for the year 2025-26, along with a notice of its 17th annual general meeting to be held on September 16, 2026. The company has achieved several milestones, including the commencement of manufacturing at Unit-I, expansion of Unit-I for manufacturing products for pharma and nutraceuticals, and acquisition of land for Unit-II. The company has also obtained FSSC 22000 certification and has listed its stock on NSE & BSE. The financial performance of the company has shown a growth in revenue and profit, with an EBITDA margin of 33.86% and a PAT margin of 25.99% in FY26.
BSECompany UpdateRegulatory21 Aug 2026
Kronox Lab Sciences Ltd
The Company has received announcement in relation of public offer to the public shareholder of the Company issued by IIFL Capital Services Limited on behalf of Indo Borax & Chemical Limited ....
Kronox Lab Sciences Ltd has received a public announcement from IIFL Capital Services Ltd on behalf of Indo Borax & Chemicals Ltd for an open offer to acquire up to 95.70 lakh equity shares, representing 25.79% of the voting share capital, from public shareholders.
BSECompany UpdateM&A20 Aug 2026
Kronox Lab Sciences Ltd
IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Kronox Lab Sciences Ltd ("Target ....
Kronox Lab Sciences Ltd has received an open offer from Indo Borax and Chemicals Ltd and Zenrock Chemicals Private Ltd to acquire up to 95,70,000 equity shares, representing 25.79% of the voting share capital, from public shareholders.
BSECompany Update▲ PositiveM&A20 Aug 2026
Kronox Lab Sciences Ltd
Joint Press Release titled Indo Boarx to acquire 64.26% stake in Kronox Lab Sciences Limited
Indo Borax and Zenrock Chemicals to acquire 64.26% stake in Kronox Lab Sciences for Rs. 246.12 crore, with an option to acquire up to 25.79% more through an open offer.
BSECompany Update▼ NegativeM&A20 Aug 2026
Kronox Lab Sciences Ltd
Promoters informed the Company about the SPA executed by them with Indo Borax & Chemicals Limited (Acquirer) and Zenrock Chemicals Private Limited (PAC)
Kronox Lab Sciences Ltd has received an intimation from its promoters that they have executed a Share Purchase Agreement (SPA) with Indo Borax & Chemicals Limited and Zenrock Chemicals Private Limited for the sale of 64.26% of the company's equity shares. The acquirer is required to make a mandatory tender offer to public shareholders.
BSECompany Update▼ NegativeFundraise20 Aug 2026
Kronox Lab Sciences Ltd
Announcement of SPA executed by Promoter with Indo Borax & Chemicals Limited (Acquirer)and Zenrock Chemicals Privated Limited (PAC)
Kronox Lab Sciences Ltd's promoters have executed a Share Purchase Agreement with Indo Borax & Chemicals Limited and Zenrock Chemicals Private Limited for the sale of 2,38,44,000 equity shares, constituting approximately 64.26% of the total paid-up equity share capital of the Company. The transaction is subject to the fulfillment of conditions precedent and other terms as set out in the SPA. The per share price for sale of shares under the SPA is ₹103.22. The Sellers have undertaken certain non-compete and non-solicit obligations for an identified period under the SPA.
BSECompany UpdateResults16 Aug 2026
Kronox Lab Sciences Ltd
Newspaper Advt. for Unaudited Financial Results for the Quarter ended June 30, 2026
Kronox Lab Sciences Ltd has published unaudited financial results for the quarter ended June 30, 2026, with total income from operations at ₹152.73 crores and net profit/(loss) for ordinary activities at ₹20.42 crores.
BSECorp. ActionDividend12 Aug 2026
Kronox Lab Sciences Ltd
Record Date for the purpose of Final Dividend (if approved by Shareholders) will be Wednesday, September 09, 2026
Kronox Lab Sciences Ltd announces record date for final dividend, if approved by shareholders, to be held on September 09, 2026. The company's register of members and share transfer books will be closed from September 10, 2026 to September 16, 2026.
BSECorp. Action12 Aug 2026
Kronox Lab Sciences Ltd
The Register of Members and Share transfer Book of the Company will remain closed from Thursday September 10, 2026 to Wednesday September 16, 2026 (both the days inclusive) for the purpose ....
Kronox Lab Sciences Ltd will close its register of members and share transfer books from September 10-16, 2026, for the purpose of its 17th Annual General Meeting and payment of final dividend for FY 2025-26, if approved.
BSEResultResults12 Aug 2026
Kronox Lab Sciences Ltd
Unaudited Financial Results for the quarter ended June 30, 2026
Kronox Lab Sciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 28.13 crores, total income at Rs. 30.64 crores, and profit before tax at Rs. 2.53 crores. The company has also appointed M/s. Diwanji & Associates as its cost auditors for the year 2026-27.
BSEBoard MeetingResults12 Aug 2026
Kronox Lab Sciences Ltd
Board Meeting held today to consider and approve Unaudited Standalone Financial Results for the Quarter ended June 30, 2026 and fix date of AGM and Record Date.
Kronox Lab Sciences Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, and has fixed the date of its 17th Annual General Meeting (AGM) and record date. The company has also appointed M/s. Diwanji & Associates as its Cost Auditors for the year 2026-27.
BSEBoard MeetingResults5 Aug 2026
Kronox Lab Sciences Ltd
Kronox Lab Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone Financial ....
Kronox Lab Sciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve Unaudited Standalone Financial Results for the quarter ended June 30, 2026.